Literature DB >> 16893831

Need for HIV/AIDS education and intervention for MTF transgenders: responding to the challenge.

Tooru Nemoto1, Lydia A Sausa, Don Operario, Joanne Keatley.   

Abstract

The purpose of this paper is to report on the use of qualitative and quantitative research to develop an HIV/AIDS education intervention for MTF transgenders. Findings revealed that MTF transgenders have high prevalence of adverse health outcomes such as HIV, substance use, and psychological problems. MTF transgenders of color-African American, Latina, and Asian Pacific Islanders-experience heightened risk due to multiple stigmas associated with ethnicity and gender identity. Based on this evidence of need, we developed a series of transgender- specific HIV prevention, substance use and mental health treatment, and health education programs. Future health programs for stigmatized gender minorities, such as MTF transgenders, will benefit from conducting descriptive studies to identify the health needs of the community, and by linking research scientists, health providers, and community agencies to form a collaborative network for delivering evidence based and community sensitive services.

Entities:  

Mesh:

Year:  2006        PMID: 16893831     DOI: 10.1300/J082v51n01_09

Source DB:  PubMed          Journal:  J Homosex        ISSN: 0091-8369


  26 in total

1.  HIV risk behaviors among male-to-female transgender persons of color in San Francisco.

Authors:  Tooru Nemoto; Don Operario; JoAnne Keatley; Lei Han; Toho Soma
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

2.  Health Implications of the Supreme Court's Obergefell vs. Hodges Marriage Equality Decision.

Authors:  Angela K Perone
Journal:  LGBT Health       Date:  2015-08-03       Impact factor: 4.151

3.  Social support, exposure to violence and transphobia, and correlates of depression among male-to-female transgender women with a history of sex work.

Authors:  Tooru Nemoto; Birte Bödeker; Mariko Iwamoto
Journal:  Am J Public Health       Date:  2011-04-14       Impact factor: 9.308

4.  Differential HIV risk for racial/ethnic minority trans*female youths and socioeconomic disparities in housing, residential stability, and education.

Authors:  Erin C Wilson; Yea-Hung Chen; Sean Arayasirikul; Marla Fisher; W Andres Pomart; Victory Le; H Fisher Raymond; Willi McFarland
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

5.  HIV among people who use drugs: a global perspective of populations at risk.

Authors:  Jamila K Stockman; Steffanie A Strathdee
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

6.  HIV Testing by Transgender Status at Centers for Disease Control and Prevention-Funded Sites in the United States, Puerto Rico, and US Virgin Islands, 2009-2011.

Authors:  Nancy Habarta; Guoshen Wang; Mesfin S Mulatu; Nili Larish
Journal:  Am J Public Health       Date:  2015-07-16       Impact factor: 9.308

7.  HIV Risk Perception, HIV Knowledge, and Sexual Risk Behaviors among Transgender Women in South Florida.

Authors:  Joseph P De Santis; Shayne D Hauglum; Diego A Deleon; Elias Provencio-Vasquez; Allan E Rodriguez
Journal:  Public Health Nurs       Date:  2016-12-05       Impact factor: 1.462

8.  Access to HIV Care and Support Services for African American Transwomen Living with HIV.

Authors:  Erin C Wilson; Sean Arayasirikul; Kelly Johnson
Journal:  Int J Transgend       Date:  2013

9.  Exploring barriers and facilitators to participation of male-to-female transgender persons in preventive HIV vaccine clinical trials.

Authors:  Michele Peake Andrasik; Ro Yoon; Jessica Mooney; Gail Broder; Marcus Bolton; Teress Votto; Annet Davis-Vogel
Journal:  Prev Sci       Date:  2014-06

10.  Stigma, mental health, and resilience in an online sample of the US transgender population.

Authors:  Walter O Bockting; Michael H Miner; Rebecca E Swinburne Romine; Autumn Hamilton; Eli Coleman
Journal:  Am J Public Health       Date:  2013-03-14       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.